Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Boyuan Yao
Observed name:
Yao, Boyuan
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Huashan Hospital
Observed institutions:
Brigham and Women's Hospital,
Shanghai Medical College of Fudan University,
Fudan University,
Pudong Medical Center,
Huashan Hospital,
State Key Laboratory of Genetic Engineering
show all 6
ORCID:
0000-0001-6448-2588
Observed ORCID:
0000-0001-6448-2588
OpenAlex ID:
A5089190380
Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors
2022
·
Fan Zhang
, Qilin Zhang
, et al.
·
Cell Research
·
110
PDF
Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET
2023
·
Qilin Zhang
, Boyuan Yao
, et al.
·
Cell Reports Medicine
·
76
PDF
Single-cell transcriptome reveals cellular hierarchies and guides p-EMT-targeted trial in skull base chordoma
2022
·
Qilin Zhang
, Lijiang Fei
, et al.
·
Cell Discovery
·
53
PDF
Diagnostic Accuracy and Value of CXCR4-targeted PET/MRI Using 68Ga-Pentixafor for Tumor Localization in Cushing Disease
2024
·
Yue Wu
, Yanfei Wu
, et al.
·
Radiology
·
24
Proteogenomic characterization of skull-base chordoma
2024
·
Qilin Zhang
, Ziyan Xu
, et al.
·
Nature Communications
·
17
PDF
FTO-mediated DSP m6A demethylation promotes an aggressive subtype of growth hormone-secreting pituitary neuroendocrine tumors
2024
·
Yunzhi Zou
, Xiaoqiong Bao
, et al.
·
Molecular Cancer
·
17
Transcription Factor ASCL1 Acts as a Novel Potential Therapeutic Target for the Treatment of the Cushing’s Disease
2022
·
Zhengyuan Chen
, Qi Jia
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
13
Low‐rank fusion convolutional neural network for prediction of remission after stereotactic radiosurgery in patients with acromegaly: a proof‐of‐concept study
2022
·
Nidan Qiao
, Damin Yu
, et al.
·
The Journal of Pathology
·
10
Digital image analysis allows objective stratification of patients with silent PIT1 ‐lineage pituitary neuroendocrine tumors
2023
·
Jiangyan Zhao
, Chenxing Ji
, et al.
·
The Journal of Pathology Clinical Research
·
8
PDF
Risk of recurrence after successful surgery for Cushing's disease and association with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study
2026
·
Qilin Zhang
, Yixin Cai
, et al.
·
The Lancet Diabetes & Endocrinology
·
7
Characterization of Somatotrope Cell Expansion in Response to GHRH in the Neonatal Mouse Pituitary
2023
·
Richard L Gonigam
, Karen E Weis
, et al.
·
Endocrinology
·
6
PDF
Efficacy and safety of BRAF-MEK inhibitors in treatment of Chinese patients with papillary craniopharyngioma: A retrospective cohort study
2025
·
Rui Han
, Xiaorong Yan
, et al.
·
Molecular Therapy Oncology
·
5
The value of targeting CXCR4 with 68Ga-Pentixafor PET/MRI for Cushing’s disease: a retrospective cohort study
2026
·
Boyuan Yao
, Yuyu Liu
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
4
SUN-070 USP8 genotype is associated with recurrence risk in Cushing’s disease: an international, retrospective, multicenter cohort study
2025
·
Qilin Zhang
, Yixin Cai
, et al.
·
Journal of the Endocrine Society
PDF
USP8 genotype is associated with recurrence risk in Cushing's disease: an international, retrospective, multicenter cohort study
2025
·
Qilin Zhang
, Yixin Cai
, et al.
·
Endocrine Abstracts
Integrated Proteogenomic Characterization across Major Histological Types of Pituitary Neuroendocrine Tumors
2022
·
Zhang, Fan
, Zhang, Qilin
, et al.
·
Figshare
Show more works
View as search
Works count:
16
Citation count:
350
H-index:
8
I10-index:
8
Year
Topic
Type